November 2007 (Vol. 6, No. 11)

Evidence-Based Reviews

Safe use of SSRIs in young adults: How strong is evidence for new suicide warning?
Michael F. Grunebaum, MD; J. John Mann, MD

Interoceptive cues: When ‘gut feelings’ point to anxiety
Kai MacDonald, MD

Modafinil: Not just for sleep disorders?
Sriram Ramaswamy, MD; Anand Mattai, MD; Daniel R. Wilson, MD, PhD

From The Editor

Innovative polypharmacy: When dopamine blockade is not enough
Henry A. Nasrallah, MD

Cases That Test Your Skills

After the ‘pink clouds,’ he sees red
Nicholas G. Pejic, MD; Stephen Klinger, MD, MPH;
Erich J. Conrad, MD; Lee T. Nesbitt, Jr., MD

Comments & Controversies

ICD shocks and anxiety: Chicken or egg?

Identify and document suicide risk

Brain injury: More clues to symptom validity

Consider adding a stimulant to antidepressant treatment

Out Of The Pipeline

Risperidone’s 2 new pediatric indications
Robert A. Kowatch, MD, PhD

Pearls

Tips for telling your patients good-bye
Abigail Kay, MD; Rajnish Mago, MD

Lost in translation: Be leery of lay language
Boadie W. Dunlop, MD

Subscribe to Current Psychiatry e-alert